Instacart Surges on Strong Q3 Results and AI-Driven Growth Strategy
New CEO Chris Rogers delivers upbeat outlook as company deepens retail partnerships and expands innovation initiatives Instacart’s (CART) shares jumped...
Elon Musk’s $1 Trillion Tesla Pay Package Sets the Stage for Historic Growth Targets
Shareholders approve record-breaking compensation plan tied to ambitious goals in vehicles, robotics, and AI. Tesla (TSLA) CEO Elon Musk has...
FAA Warns of Major Flight Cuts as Government Shutdown Deepens
Up to 10% of air traffic could be reduced across 40 major markets, threatening thousands of flights ahead of the...
Albemarle Corporation’s Road to $200: Big Chemistry, Big Ambition
How a leading lithium-and-specialty-chemicals firm could scale toward a $200 stock price despite near-term headwinds. Albemarle Corporation (ALB) may not...
Can AMD Really Hit $1,000?
What must go right for Advanced Micro Devices to make the leap from AI contender to trillion-plus juggernaut Advanced Micro...
Palantir’s Soaring Valuation Faces Wall Street Scrutiny After Strong Earnings
Despite impressive revenue growth and raised guidance, analysts question whether the AI defense firm’s sky-high valuation is sustainable. Palantir Technologies...
U.S.-Approved Deal Expands Microsoft’s AI Footprint in the Middle East
Microsoft announced Monday that it will ship over 60,000 of Nvidia’s most advanced artificial intelligence chips to the United Arab...
Kimberly-Clark and Kenvue Unite to Form Consumer Health Giant
Kimberly-Clark, the maker of household staples like Kleenex and Huggies, has announced plans to acquire Tylenol producer Kenvue in a...
Amazon Soars 9% After Beating Q3 Estimates on Strong AWS Growth
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6 Amazon (AMZN) shares surged more than 9% in...
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
Study in eBioMedicine shows strong disease control and survival benefits across multiple tumor types with minimal toxicity Intensity Therapeutics (INTS),...
